Rfk Jr. accuses FDA for the influence of the drug industry that prevented alternative treatments

In a speech broadcast on the campus of Maryland of the Food and Drug Administration on Friday morning, Robert F. Kennedy Jr. He introduced himself as a Health Secretary of the Nation with a speech that touches everything, from hunting birds to pollution at Erie Lake at CIA

Mr Kennedy told members of the staff of the Agency, with the loss of 20 % of their workforce under the revision of the Department of Health and Human Services, to avoid the impulse of protecting companies regulating.

Dismissions, voluntary departures and funding cuts have already decimated sections governing tobacco supervision, drug approval process, cow’s milk testing and cheese for bird flu and food safety and food protection.

In his observations on Friday, Mr Kennedy suggested that the reason why the organization did not approve “alternative drugs” was because of his submission to good companies. He has previously accused the FDA of suppressing the processes of raw milk, ibermectin and stem cells. The veterans of the service have argued that alternatives often fail to pass on safety and efficiency standards.

He called on staff to resist the temptation to serve a small group of wealthy companies at the cost of public health. “We want to get out of it so that we can make our children healthy,” he said, according to a video and a copy of his speech he shared with the New York Times.

At another point, he said: “The deep state is real”, a derogatory reference to the distinct federal bureaucracy that accused President Trump as an obstacle to achieving his goals in his first term.

Mr Kennedy also called the FDA “a sock puppet” for the industries it is supposed to regulate, the language it has used in the past.

Andrew Nixon, a spokesman for the Department of Health and Human Services, said in a statement that with his observations on Friday, Mr Kennedy “was telling the truth that many Americans already know”.

Pharmacists have benefited from a series of FDA efforts to accelerate certain drug approvals or encourage companies to develop medicines for serious diseases that have no treatments. Agency officials said the programs are aimed at helping patients.

Said Mr. Kennedy that the “fast -track regulations” were well -meaning. But over time, he said: “Organs have become for the established bodies, the very powerful establishments in the industry, to exclude dissidents and, you know, rare diseases and alternative medicines and these things.”

Mr Kennedy also urged FDA employees to speak if their higher products Greenlight are inappropriate. “If your boss is wrong, if they approve something that should not be approved, we want to hear,” he said.

Dr. Marty Makary, the new FDA Commissioner, introduced Mr Kennedy at a Friday meeting and approved his goals to create a healthier food supply. He acknowledged that cuts in the organization “were tough on the ground” for some staff. He said that the changes were “aimed at consolidating, more effective and creating more teamwork”.

Mr. Kennedy and Dr. Makary was broadcast in a video aired on the organization Oak campus of the Organization in Suburban Maryland.

Mr Kennedy remembered in the speech that he was a child visiting his father, Attorney General Robert F. Kennedy, at the Washington Ministry of Justice and was watching Falcons Peregrine nest in the dome in the old post building. He also discussed his experiences that worked with people with mental disabilities and the battles he waged as an environmental lawyer.

Mr Kennedy also complained about the rules governing the organization’s food department that allows companies to certify that the new ingredients are generally recognized as safe. The measure initially covered ingredients such as salt or vinegar as acceptable in non -review. However, since then, thousands of ingredients have been added to the supply of food without warning or testing by the body.

Food companies are required to provide component revisions to on -the -spot FDA inspectors, but these inspections can be carried out once every five years or less. Mr Kennedy called for an end to allow food companies to certify that the ingredients are safe.

“We literally do not try chemicals before they are added to our food,” he said. “Everything is sealed by industry as generally recognized as safe.”

He continued to attribute nation’s diabetes rates to the vacuum, adding that sugar also plays a role.

The speech is reminiscent of a position of social media by Mr Kennedy in October, accusing the FDA of faking a “public health war”. He said that the organization was involved in a “aggressive repression” of a series of unproven or unsafe products, including raw milk, chelating compounds, Ibermectin and “anything else that promotes human health and cannot be guaranteed by Pharma”.

The post continued: “If you are working for the FDA and you are part of this corrupt system, I have two messages for you: 1. Keep your files and 2. Pack your bags.”

The organization is still unfolding from thousands of job cuts and voluntary departures in the weeks since Mr Kennedy was appointed Health Secretary. FDA officials who have left in recent weeks include staff members considering by -products who can cause cancer and others working with international food safety executives to try to stop infected products from entry into the United States.

The cuts in some areas were so deep that former FDA officials suggested that they could endanger billions of dollars in fees that the pharmaceutical industry pays for the organization to ensure that the drug approval process is sufficiently staffed.

The Drugmakers were anxious about what Mr Kennedy’s leadership would mean for their interests. They are worried that cuts in the body will slow down drug reviews, including the start of clinical trials, and add delays to final approval.

A public letter signed by dozens of investors and biotechnology executives said industry leaders were “deeply concerned about the current situation of the organization and the future”.

“Some of us have already encountered regulatory difficulties that we believe are the consequences of losing the experienced FDA staff,” the letter said.